health
Far-Field Potentials Emerge as SMA Disease Progression Biomarker
Australian researchers find far-field potential amplitude significantly lower in SMA patients than healthy controls, suggesting FFP may serve as a reliable biomarker for tracking disease progression.
MED confidence
Coverage (0 articles)
No articles in this topic yet.